Jefferies Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-5,000
Closed -$63.3K – 1663
2024
Q2
$63.3K Buy
+5,000
New +$50.3K ﹤0.01% 1312
2023
Q2
– Sell
-120,300
Closed -$834K – 1909
2023
Q1
$834K Buy
120,300
+35,700
+42% +$328K 0.01% 955
2022
Q4
$870K Buy
+84,600
New +$1.49M 0.01% 909

Other funds holding NVAX

Jefferies Financial Group's NVAX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Novavax (NVAX) in Q2 2026, closing a stake of 673,120 shares — an estimated $5.48M sold.

Jefferies Financial Group first reported a position in NVAX in Q4 2022 and held it in 8 quarters. The position peaked at $5.48M in Q1 2026. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Jefferies Financial Group reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 673,120 Novavax shares in Q2 2026, an estimated $5.48M.
  • Jefferies Financial Group first reported a position in Novavax in Q4 2022 and held it in 8 quarters.
  • Jefferies Financial Group's Novavax position peaked at $5.48M in Q1 2026.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.